These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24379695)

  • 1. Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care.
    Andrews JS; Wu N; Chen SY; Yu X; Peng X; Novick D
    J Pain Res; 2013; 6():825-35. PubMed ID: 24379695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of duloxetine and celecoxib in osteoarthritis patients.
    Peng X; Wu N; Chen SY; Yu X; Andrews JS; Novick D
    Curr Med Res Opin; 2013 Sep; 29(9):1161-9. PubMed ID: 23777314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of pain medication selection among patients diagnosed with fibromyalgia.
    Boulanger L; Wu N; Chen SY; Nagar S; Fraser K; Bernauer MJ; Zhao Z; Zhao Y
    Pain Pract; 2012 Apr; 12(4):266-75. PubMed ID: 21899718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.
    Sun P; Peng X; Sun S; Novick D; Faries DE; Andrews JS; Wohlreich MM; Wu A
    Pain Pract; 2014 Jan; 14(1):22-31. PubMed ID: 23489659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
    Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
    J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
    Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine use in chronic low back pain: treatment patterns and costs.
    Ivanova JI; Birnbaum HG; Kantor E; Schiller M; Swindle RW
    Pharmacoeconomics; 2012 Jul; 30(7):595-609. PubMed ID: 22686662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and compliance among U.S. patients receiving pazopanib or sunitinib as first-line therapy for advanced renal cell carcinoma: a retrospective claims analysis.
    Byfield SA; McPheeters JT; Burton TM; Nagar SP; Hackshaw MD
    J Manag Care Spec Pharm; 2015 Jun; 21(6):515-22. PubMed ID: 26011553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.
    Peng X; Sun P; Novick D; Andrews J; Sun S
    J Pain Res; 2014; 7():37-46. PubMed ID: 24470771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of select medications prior to duloxetine initiation among commercially-insured patients.
    Bernauer M; Wu N; Chen SY; Peng X; Boulanger L; Zhao Y
    J Pain Res; 2012; 5():271-8. PubMed ID: 23049276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States.
    Liu Y; Qian C; Yang M
    J Manag Care Spec Pharm; 2016 Mar; 22(3):263-71. PubMed ID: 27003556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
    Kim SC; Landon JE; Lee YC
    Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators.
    Marlow NM; Simpson KN; Vaughn IA; Jo A; Zoller JS; Short EB
    Pain Pract; 2018 Feb; 18(2):154-169. PubMed ID: 28419725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care.
    Gore M; Zlateva G; Tai KS; Chandran AB; Leslie D
    Pain Pract; 2011; 11(2):167-79. PubMed ID: 20723096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
    Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
    BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.